WHO official says agency will stop hydroxychloroquine arm of COVID-19 Solidarity Trial

Dr. Ana Maria Henao-Restrepo, a medical officer at WHO's Department of Immunization Vaccines and Biologicals, said during a media briefing in Geneva on Wednesday that the decision was made based on preliminary information from a separate hydroxychloroquine study in the United Kingdom that showed no benefit of the antimalarial against COVID-19, and early data from the Solidarity Trial itself.

"A decision was made to stop the randomization with the hydroxychloroquine trial on the basis of two pieces of information. The first, the data that was published by the UK trial and second, the data that was available to us from the Solidarity Trial," Henao-Restrepo said, later clarifying in the briefing that"they have concluded that the hydroxychloroquine arm will be stopped from the Solidarity Trial.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Consolacion reports three new COVID-19 casesThe municipality of Consolacion has recorded three new cases of coronavirus disease (COVID-19) on Tuesday, June 16, 2020.
Source: cebudailynews - 🏆 8. / 71 Read more »

Heart disease, diabetes significantly raise risk of hospitalization, death from COVID-19: US study
Source: ANCALERTS - 🏆 26. / 50 Read more »

COVID-19 to change the way tourists will travelThe massive shutdown of borders has prompted some Filipino travelers to cancel their flights amid the threat of the dreaded coronavirus disease (COVID-19).
Source: manilabulletin - 🏆 25. / 51 Read more »